Clinical Trial Update: Safety and Efficacy Study in Hepatitis C Patients With PHN121 [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 safety and efficacy study in hepatitis C patients using PHN121 was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PHN121

Snippet

Sponsor: PhytoHealth Corporation | Conditions: Hepatitis C Virus Infection | Phase 1, Phase 2 | Status: TERMINATED